Relypsa is now Vifor Pharma! The final stage of our integration is complete with the renaming of Relypsa to Vifor Pharma, marking a significant milestone in our journey to being the global leader in iron deficiency, nephrology and cardio-renal therapies. Our US office is located in Redwood City, California, where with the expertise from our teams, we continue to strive to help patients around the world with severe and chronic diseases, lead better, healthier lives. We are proud to have developed Veltassa® (patiromer) for oral suspension, based on our rich legacy in polymer science. Follow https://www.linkedin.com/company/viforpharma to stay up to date on the latest news and milestones. (Our community guidelines: viforpharma.com/linkedin-cg)